Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 4—April 2013
Research

Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil

Eliane Terezinha Afonso, Ruth Minamisava, Ana Luiza Bierrenbach, Juan Jose Cortez Escalante, Airlane Pereira Alencar, Carla Magda Domingues, Otaliba Libanio Morais-Neto, Cristiana Maria Toscano, and Ana Lucia AndradeComments to Author 
Author affiliations: Federal University of Goiás, Goiania, Goiás, Brazil (E.T. Afonso, R. Minamisava, A.L. Bierrenbach, O.L. Morais-Neto, C.M. Toscano, A.L. Andrade); Pontifical Catholic University of Goiás, Goiania (E.T. Afonso); Ministry of Health, Brasilia, Brazil (J.J.C. Escalante, C.M. Domingues); University of Brasília, Brasília (C.M. Domingues); University of São Paulo, São Paulo, Brazil (A.P. Alencar)

Main Article

Figure 4

Trends in rates of hospitalization for pneumonia (dark gray) and bronchiolitis (light gray) among children 2 months–2 years of age in 5 cities, Brazil, January 2005–August 2011. PCV10, 10-valent pneumococcal vaccine.

Figure 4. . . Trends in rates of hospitalization for pneumonia (dark gray) and bronchiolitis (light gray) among children 2 months–2 years of age in 5 cities, Brazil, January 2005–August 2011. PCV10, 10-valent pneumococcal vaccine.

Main Article

Page created: March 13, 2013
Page updated: March 13, 2013
Page reviewed: March 13, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external